Effective immediately, the Wyoming Department of Health is asking Wyoming providers to temporarily cease administration of the Johnson & Johnson (Janssen) COVID-19 vaccine pending additional recommendations from the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Advisory Committee on Immunization Practices.
According to the Joint press release from the CDC and FDA, as of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.
Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.
Sweetwater County has given 540 Johnson & Johnson Vaccines through April 12, according to the Wyoming Department of Health. The website shows 9,513 given statewide.
If you have received a Johnson & Johnson Vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their healthcare provider.
With the CDC and FDA recommendations to pause Johnson & Johnson vaccine distribution, all Johnson & Johnson clinics scheduled for April 14-16 in Sweetwater County have been changed to Pfizer vaccine.